The clinical symptoms of Parkinson's disease.

Cited by (1,401)

Items 701–800 of 1,401

1. Teorias causais, sintomas motores, sintomas não-motores, diagnóstico e tratamento da Doença de Parkinson: uma revisão bibliográfica
   Francisco Elezier Xavier Magalhães, Valécia Natália Carvalho da Silva, Jacks Renan Neves Fernandes, Antônio Thomaz de Oliveira, Thayaná Ribeiro Silva Fernandes, Silmar Silva Teixeira · 2022 · Research Society and Development
2. Early Prediction of Parkinson’s Disease using Multiple SVM Classifiers
   Rakesh Kumar, Meenu Gupta, Simarpreet Singh · 2023 · International Conference on Sustainable Computing and Smart Systems (ICSCSS)
3. A genome-wide association study coupled with machine learning approaches to identify influential demographic and genomic factors underlying Parkinson’s disease
   Md Asad Rahman, Jinling Liu · 2023 · Frontiers in Genetics
4. Multimodal Fusion for Enhanced Parkinson's Disease Screening: Integrating Brain MRI, Hand Drawing, Facial Expressions, and Voice Analysis
   Naveen Warnakulasuriya, Shalinika De Silva, Janani Madushika, Sadali Gamage, Sanath Jayawardena, Anuradha Karunasena · 2023 · International Conference on Advancements in Computing (ICAC)
5. Machine-learning classification with additivity and diverse multifractal pathways in multiplicativity
   Madhur Mangalam, Henrik Seckler, Damian G. Kelty‐Stephen · 2024 · Physical Review Research
6. Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
   Genta Ito, Taisuke Tomita · 2017 · Journal of Visualized Experiments
7. Ionic Cocrystals of Levodopa and Its Biological Precursors l -Tyrosine and l -Phenylalanine with LiCl
   Oleksii Shemchuk, Dario Braga, Fabrizia Grepioni · 2019 · Crystal Growth & Design
8. Using Multi-Feature Fusion for Detecting Freezing of Gait Episodes in Patients with Parkinson's Disease
   Hadeer Elziaat, Nashwa El-Bendary, Ramadan Moawad · 2020
9. PasoDoble, a Proposed Dance/Music for People With Parkinson's Disease and Their Caregivers
   Lydia Giménez‐Llort, Lidia Castillo-Mariqueo · 2020 · Frontiers in Neurology
10. Solving The Maze of Diagnosing Parkinson’s Disease based on Portable EEG Sensing to be Adaptable to Go In-The-Wild
    Md Ashiqur Rahman, Abdullah Aman Tutul, A. B. M. Alim Al Islam · 2020 · International Conference on Networking, Systems and Security (NSysS)
11. Association between subjective autonomic dysfunction and fatigue in Parkinson’s disease in southern Chinese
    Zongbo Zhao, Hui Liu, Jianzhong Xue · 2021 · Neurological Sciences
12. An optimized Parkinson's disorder identification through evolutionary fast learning network
    Bouslah Ayoub, Nora Taleb · 2021 · International Journal of Intelligent Computing and Cybernetics
13. Speech characteristics of parkinson disease
    Zeynep Zeliha Sonkaya, Mustafa Ceylan, Ali Rıza Sonkaya · 2021 · Medical Science and Discovery
14. Wrist Movement Variability Assessment in Individuals with Parkinson’s Disease
    Lígia Reis Nóbrega, Ariana Moura Cabral, Fábio Henrique Monteiro Oliveira, Adriano de Oliveira Andrade, Sridhar Krishnan, Adriano Alves Pereira · 2022 · Healthcare
15. Sporadic SNCA mutations A18T and A29S exhibit variable effects on protein aggregation, cell viability and oxidative stress
    Neha Joshi, Tanveera Rounaque Sarhadi, Atchaya Raveendran, Shirisha Nagotu · 2023 · Molecular Biology Reports
16. Does Impaired Plantar Cutaneous Vibration Perception Contribute to Axial Motor Symptoms in Parkinson’s Disease? Effects of Medication and Subthalamic Nucleus Deep Brain Stimulation
    Tobias Heß, Peter Themann, Christian Oehlwein, Thomas L. Milani · 2023 · Brain Sciences
17. Plasma miRNA Biomarker Signatures in Parkinsonian Syndromes
    Stylianos Ravanidis, Anastasia M. Bougea, Christos Koros, Athina‐Maria Simitsi, Panagiotis Kokotis, Leonidas Stefanis, Epaminondas Doxakis · 2025 · Molecular Neurobiology
18. Role and mechanism of herbal bioactives in treatment of Parkinson's disease: A promising therapeutic approach
    Manpreet Kaur, Mukta Gupta · 2025 · South African Journal of Botany
19. Challenges and opportunities in nanotherapeutics targeted for central nervous system disorders
    Joel M. Yong, Karen Hakobyan, Sk Al Zaheri Mahmud, Daniel Johnson, Jacob Lee, Ashish Dhar Diwan, Zi Gu, Gila Moalem‐Taylor, Guangzhao Mao · 2025 · Nanoscale
20. Nano-conjugation of small molecule modulators of protein aggregation: Enhancing the therapeutic precision
    Syed Ifrah Manzoor, Ishfaq Ahmad Ahanger, Majid Rasool Kamli, Maqsood Ahmad Malik, Tanveer Ali Dar · 2025 · International Journal of Biological Macromolecules
21. Role of mitochondria in neuronal function and survival in the enteric and central nervous systems
    İrem KURAL, Lobke Marie M. Mombeek, David M. Wilson · 2026 · Cellular and Molecular Life Sciences
22. Molecular Mechanisms of Dopaminergic Neuron Degeneration in Parkinson’s Disease: A Comprehensive Review
    MD. Abubakar, Shahnaz Alom, Farak Ali, Sheikh Rezzak Ali, Krishnendu Adhikary, S. Sarika, Prakash Kumar Gupta, Eswara Rao Puppala, Krishna Murti, Sachchida Nand et al. · 2026 · Current Neuropharmacology
23. Support needs of people with younger onset Parkinson's disease: An interpretative phenomenological analysis
    Clare Stephenson, Allyson Flynn, Anthony Overs · 2022 · Collegian Journal of the Royal College of Nursing Australia
24. Identification of Genomic Associations Between Parkinson's and Neurodegenerative Diseases Using Bioinformatics Models
    Md. Shohel Rana, Nitun Kumar Podder, Humayan Kabir Rana · 2023 · International Conference on Electrical, Computer and Communication Engineering
25. Symptomatology and Clinical Features of Parkinson's Disease
    Abdelaati El Khiat, Bilal El‐Mansoury, Driss Ait Ali, Mohamed El Koutbi, Kamal Kaoutar, Youssef Ait Hamdan, Brahim El Houate, Lahcen Tamegart, Kamal Smimih, Adnane Hakam et al. · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
26. Doença de Parkinson: epidemiologia, manifestações clínicas, fatores de risco, diagnóstico e tratamento
    Letícia Casalli Couto, Brenda Passos Besagio, Emilly Caetano De Andrade · 2023 · Brazilian Journal of Health Review
27. Human Nasal Inferior Turbinate-Derived Neural Stem Cells Improve the Niche of Substantia Nigra Par Compacta in a Parkinson’s Disease Model by Modulating Hippo Signaling
    Junwon Choi, Sun Wha Park, Hyun Ji Lee, Do Hyun Kim, Sung Won Kim · 2024 · Tissue Engineering and Regenerative Medicine
28. Bicycling for Rehabilitation of Persons With Parkinson Disease: A Scoping Review
    John Luca Palmieri, Lesley Jones, Margaret L. Schenkman, Judith E. Deutsch · 2024 · Neurology Report
29. Multi-Shared-Task Self-Supervised CNN-LSTM for Monitoring Free-Body Movement UPDRS-III Using Wearable Sensors
    Mustafa Shuqair, Joohi Jimenez Shahed, Behnaz Ghoraani · 2024 · Bioengineering
30. The impact of aerobic exercise dose based on ACSM recommendations on patients with Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
    Wenlai Cui, Zepeng Hu, Jian Li, Siji Wang, Ruilin Xu · 2024 · Frontiers in Aging Neuroscience
31. Exploring motor imagery as a therapeutic intervention for Parkinson’s disease patients: a scoping review
    Maxime Michel, Elena Terragno, Matthieu Béreau, Éloi Magnin, Nicolas Gueugneau, Antônio Vinícius Soares, Yoshimasa Sagawa · 2024 · Frontiers in Neurology
32. Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B Inhibitors
    Neha Rana, Parul Grover · 2024 · CNS & Neurological Disorders - Drug Targets
33. Trends in mortality and disparities in dilated cardiomyopathy across gender, race, and region in the United States (1999-2020)
    Taimoor Ashraf, Omar Abunada, Aashish Kumar, Saboor Ahmed, Muhammad Basit Ali Siddiqui, Umer Farooque Memon, Shah Dev, Aashish Meghjiani, Muskan Turesh, Govinda Khatri et al. · 2024 · Annals of Medicine and Surgery
34. Personalized medication recommendations for Parkinson’s disease patients using gated recurrent units and SHAP interpretability
    Atiye Riasi, Mehdi Delrobaei, Mehri Salari · 2025 · Scientific Reports
35. Micrographia in Parkinson's Disease: Automatic Recognition through Artificial Intelligence
    Francesco Asci, Gaetano Saurio, Giulia Pinola, Marco Falletti, Alessandro Zampogna, Martina Patera, Francesco Fattapposta, Simone Scardapane, Antonio Suppa · 2025 · Movement Disorders Clinical Practice
36. Roles of glia-derived extracellular vesicles in central nervous system diseases: an update
    Hao Sun, Xiaojuan Su, Shiping Li, Dezhi Mu, Yi Qu · 2021 · Reviews in the Neurosciences
37. Studying Lipid-Related Pathophysiology Using the Yeast Model
    Tyler Ralph-Epps, Chisom Onu, Linh Vo, Michael W. Schmidtke, Anh Le, Miriam L. Greenberg · 2021 · Frontiers in Physiology
38. A Ranking-based Weakly Supervised Learning model for telemonitoring of Parkinson’s disease
    Dhari F. Alenezi, Hang Shi, Jing Li · 2022 · IISE Transactions on Healthcare Systems Engineering
39. Coconut milk ameliorates motor and non-motor deficits in the alpha-synuclein transgenic Drosophila melanogaster model for Parkinsonism
    Olumayowa Idowu · 2022 · SLU Journal of Science and Technology
40. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation
    Honoka Fujimori, Takuya Ohba, Shinsuke Nakamura, Masamitsu Shimazawa, Hideaki Hara · 2023 · Biological and Pharmaceutical Bulletin
41. Identification of novel dual acting ligands targeting the adenosine A2A and serotonin 5-HT1A receptors
    Iman Touati, Mohnad Abdalla, Yassir Boulaamane, Nawal Al‐Hoshani, Abdulaziz Alouffi, Mohammed Réda Britel, Amal Maurady · 2023 · Journal of Biomolecular Structure and Dynamics
42. Transcranial direct current stimulation improves motor function in rats with 6-hydroxydopamine-induced Parkinsonism
    Ryota Tamura, Shinnosuke Dezawa, Junpei Kato, Mariko Nakata, Nobuo Kunori, Ichiro Takashima · 2023 · Behavioural Brain Research
43. Efficacy and safety of acupuncture therapy for neuropsychiatric symptoms among patients with Parkinson's disease: A systematic review and meta-analysis
    Weiqiang Tan, Fengxi Xie, Jixi Zhou, Zhaoquan Pan, Muxi Liao, Lixing Zhuang · 2024 · Clinical Rehabilitation
44. Pharmacological Assessment of Aqueous Ethanolic Extract of Thalictrum Foetidum Against Haloperidol-Induced Parkinson’s Like Symptoms in Animal Model: A Dose-Dependent Study With Mechanistic Approach
    Han Jiang-yu, Xu Hao, Mishal Fatima, Zunera Chauhdary, Ayesha Jamshed, Hafiz Muhammad Abdur Rahman, Rida Siddique, Muhammad Asif, Saba Rana, Liaqat Hussain · 2024 · Dose-Response
45. Ketone ester–enriched diet ameliorates motor and dopamine release deficits in MitoPark mice
    Vikrant R. Mahajan, Jacob A. Nadel, Michael Todd King, Robert J. Pawlosky, Margaret I. Davis, Richard L. Veech, David M. Lovinger, Armando G. Salinas · 2024 · European Journal of Neuroscience
46. Neurobiological mechanism of music improving gait disorder in patients with Parkinson’s disease: a mini review
    Lingzhi Huang, Zhi Qi · 2025 · Frontiers in Neurology
47. A systems biology approach to identifying genetic factors affected by aging, lifestyle factors, and type 2 diabetes that influences Parkinson's disease progression
    Najmus Sakib, Utpala Nanda Chowdhury, Md. Babul Islam, Shamim Ahmad, Mohammad Ali Moni · 2020 · Informatics in Medicine Unlocked
48. Beneficial Microbes as Novel Microbial Cell Factories in Nanobiotechnology: Potentials in Nanomedicine
    Elijah Adegoke Adebayo, Iyabo Christianah Oladipo, Jelili Abiodun Badmus, Agbaje Lateef · 2021 · Materials horizons
49. Curcuma longa extract ameliorates motor and cognitive deficits of 6-hydroxydopamine-infused Parkinson’s disease model rats
    Sujan Bhowmick, Marzan Sarkar, Jakir Hussain, Mehedi Hassan, Mafroz Ahmed Basunia, Taslima Nahar, Md. Azizur Rahman, Borhan Uddin, Shahdat Hossain · 2021 · Oriental Pharmacy and Experimental Medicine
50. Istradefylline Versus Opicapone for “Off” Episodes in Parkinson’s Disease: A Systematic Review and Meta-Analysis
    Alok D. Singh, Dhyuti Gupta, Suryaprakash Dhaneria, Pranav G. Sheth · 2021 · Annals of Neurosciences
51. Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers
    Samar O. El-Ganainy, Tony Cijsouw, Mennatallah A. Ali, Susanne Schoch, Amira Sayed Hanafy · 2022 · Expert Review of Neurotherapeutics
52. Review on the effect of acupuncture on Parkinson's disease over the last 5 years
    Seo-Young Kim, Young-Woo Lim, Eunjoo Kim, Seong-Uk Park · 2022 · 대한한의학회지
53. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson’s Disease
    Bruk Getachew, Antonei Benjamin Csoka, Robert Copeland, Kebreten F. Manaye, Yousef Tizabi · 2022 · Neurotoxicity Research
54. The Evaluation of Vitamin E and TiO2 Nanoparticles Administration in Parkinson's Rat Model.
    Behdokht Jamali, Malihe Entezari, Nahid Babaei · 2023 · PubMed
55. Efficacy and safety of botulinum toxin for treating motor dysfunction in patients with Parkinson’s disease: a systematic review and meta-analysis
    Yuqi Yang, Tong Zhang, Lixu Liu, Lei Shan, Xueyan Hu, Lingyu Yang, Fei Gao, Xiaoli Wu, Hanzhi Li · 2023 · BMJ Open
56. Oral administration of sophoricoside (SOP) inhibits neuronal damage and neuroinflammation to curb neurodegeneration in Parkinson's disease
    Hefei Wang, Dewei He, Zhe Li, Xiyu Gao, Shuo Yang, Mingchi Cui, Bojian Ye, Bingxu Huang, Shoupeng Fu, Dianfeng Liu · 2023 · Chemico-Biological Interactions
57. From Protocol to Product: Ventral Midbrain Dopaminergic Neuron Differentiation for the Treatment of Parkinson’s Disease
    J. Kusena, Robert J Thomas, Mark McCall, Samantha L. Wilson · 2019 · Regenerative Medicine
58. Solving the Puzzle of Neurodegeneration
    Michael S. Wolfe · 2018 · Elsevier eBooks
59. A computational model of loss of dopaminergic cells in Parkinson’s disease due to glutamate-induced excitotoxicity
    Vignayanandam Ravindernath Muddapu, Alekhya Mandali, V. Srinivasa Chakravarthy · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
60. A Network based Approach to Identify the Genetic Influence Caused by Associated Factors and Disorders for the Parkinsons Disease Progression
    Najmus Sakib, Utpala Nanda Chowdhury, Md. Babul Islam, Julian M.W. Quinn, Mohammad Ali Moni · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
61. Exploration of novel phytochemicals as α-synuclein aggregation inhibitors in the context of Parkinson’s disease therapy: an in-silico approach
    Garima Gupta, Deepika Joshi, Gopeshwar Narayan · 2025 · In Silico Pharmacology
62. The Relationship Between Neuropsychiatric Disorders and the Oral Microbiome
    Julia Kalinowski, Tasneem Ahsan, Mariam Ayed, Michelle Marie Esposito · 2025 · Bacteria
63. A mixed methods feasibility study of a ketogenic diet as treatment for Parkinson’s disease
    Kate Worster, Dana Dharmakaya Colgan, Alexandra Adorno Vita, Christine McClure, Lita Buttolph, Romilly Hodges, Angela Senders, Andy Erlandsen, Fawzy Elbarbry, Heather L. Zwickey · 2025 · Frontiers in Nutrition
64. DS-HViT: A Dual-Stream Hierarchical Vision Transformer for Multi-Scale Analysis of Parkinson's Disease Handwriting
    Ayoub Louja, Yassin Zaiouane, Abdellah Jamali · 2025 · Engineering Technology & Applied Science Research
65. Gene therapy for Parkinson’s disease: current landscape, translational challenges, and future directions
    Vito Evola, Mayur S. Parmar · 2026 · Expert Review of Neurotherapeutics
66. The role of ALOX15 in inflammation-related diseases
    Rong Tang, Chao-Yang Gong, Yang Liu, Hai-lian Zhong, Ying-bin Wang, Hai-yu Zhou · 2026 · Frontiers in Immunology
67. Pattern and treatment of Parkinson’s disease at different health care levels in Bangladesh: a hospital based survey
    Sharmin Sultana, Md. Lokman Hossain, M. Nazma Parvin · 2020 · International Journal of Scientific Reports
68. Association of depression with disease duration, quality of life and adherence in Parkinson’s disease: A cross sectional study
    Subhash Samanta, Manisha Bisht, M Kanimozhi, Niraj Kumar, Shailendra S. Handu · 2023 · Journal of Family Medicine and Primary Care
69. Effects of Intracerebral Aminophylline Dosing on Catalepsy and Gait in an Animal Model of Parkinson’s Disease
    Érica de Moraes Santos Corrêa, Gustavo Christofoletti, Albert Schiaveto de Souza · 2024 · International Journal of Molecular Sciences
70. Dynamic channelwise functional-connectivity states extracted from resting-state EEG signals of patients with Parkinson’s disease
    Hao Ding, Xinmeng Weng, Minghuan Xu · 2024 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
71. Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo
    Min Shao, Chen Zhao, Zhijian Pan, Xuanjun Yang, Gao Cheng, Gloria Hio-Cheng Kam, Hefeng Zhou, Simon Ming‐Yuen Lee · 2024 · Chemico-Biological Interactions
72. Correlations Between Dietary Magnesium Consumption and Magnesium Depletion Score in Relation to Parkinson’s Disease: A Population-Based Study
    Yanmei Cen, Lu Wang, Siqi Zhang · 2024 · Biological Trace Element Research
73. Identifying Parkinson’s disease and its stages using static standing balance
    Dawoon Jung, Dallah Yoo, Jin Wook Kim, Tae Beom Ahn, Kyung-Ryoul Mun · 2024 · npj Digital Medicine
74. Parkinson’s disease tremor prediction towards real-time suppression: A self-attention deep temporal convolutional network approach
    Guan Yuan Tan, A. S. M. Bakibillah, Ping Yi Chan, Chee Pin Tan, Surya Girinatha Nurzaman · 2025 · Computers in Biology and Medicine
75. Biomarker Discovery in Wilson’s Disease—A Path Toward Improved Diagnosis and Management: A Comprehensive Review
    Marta Wolska, Zofia Wicik, Sara Ahmadova, Dagmara Maria Mirowska-Guzel, Marek A Postula, Anna Członkowska, Ceren Eyileten · 2025 · Molecular Neurobiology
76. Is the Voltage-Dependent Anion Channel a Major Player in Neurodegenerative Diseases?
    Sebastian Neumann, Rolf Heumann · 2025 · International Journal of Molecular Sciences
77. Caudate serotonin signaling during social exchange distinguishes essential tremor and Parkinson’s disease patients
    Alec E. Hartle, Kenneth T. Kishida, L. Paul Sands, Seth R. Batten, Leonardo S. Barbosa, Dan Bang, Terry M. Lohrenz, Jason P. White, Arian Kolahi Sohrabi, Rebecca Calafiore et al. · 2025 · Nature Communications
78. Dance and Parkinson's: Biological perspective and rationale
    Jessica McMahon, Paul Louis Chazot · 2020 · Lifestyle Medicine
79. The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson’s Disease
    Isaac Bul Deng, Sanjay Garg, Xin‐Fu Zhou, Larisa Bobrovskaya · 2022 · Frontiers in Bioscience-Scholar
80. An ensemble‐based feature selection framework for early detection of Parkinson's disease based on feature correlation analysis
    Sarfaraz Masood, Khwaja Wisal Maqsood, Om Pal · 2021 · Mathematical Methods in the Applied Sciences
81. Living with Parkinson’s disease: A qualitative study of spousal perspectives
    Itay Ressler, Avital Gershfeld-Litvin · 2022 · Journal of Health Psychology
82. Do prescription stimulants increase risk of Parkinson’s disease among adults with attention-deficit hyperactivity disorder? A retrospective cohort study
    Hailey M Kindt, Wen‐Jan Tuan, Curtis Bone · 2023 · Family Practice
83. Parkinson’s Disease Prognosis Using The ResNet-50 Model From Speech Features
    Shafeena M.B, Suja Vijayan · 2022
84. Protective effect of GK2 fused BLVRA protein against oxidative stress‐induced dopaminergic neuronal cell damage
    Yeon Joo Choi, Hyun Jung Kwon, Min Jea Shin, Dae Won Kim, Gi Soo Youn, Jung Hwan Park, Hyeon Ji Yeo, Eun Ji Yeo, Hyeong Seop Kim, Lee Re Lee et al. · 2023 · FEBS Journal
85. Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?
    Ava Nasrolahi, Zahra Shabani, Saeed Sadigh‐Eteghad, Hanieh Salehi‐Pourmehr, Javad Mahmoudi · 2023 · Current Stem Cell Research & Therapy
86. A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres
    Xinyu Zhao, Chunmin Guo, Hong Zhang, Xin Yu, Guagnying Du, Jingwei Tian, Wanhui Liu, Tao Song, Xiaobo Chen, Wei Guo · 2023 · Basic & Clinical Pharmacology & Toxicology
87. Intervention components in the self-management of Parkinson’s: a mixed-methods synthesis of qualitative and quantitative evidence
    Megan Armstrong, Kate R Walters, Nathan Davies, Danielle Nimmons, Jennifer Pigott, Joy Read, Anette E. Schrag · 2024 · BMC Health Services Research
88. Enhancing Parkinson’s Disease Detection Through Handwriting Analysis: A Deep Learning Approach with Segmentation and Transfer Learning
    S.M. Rhydh Arnab, Mohammad Rakin Uddin, Atik Jawad · 2023 · International Conference on Computer and Information Technology (ICCIT)
89. The Effect of Oropharyngeal Resting Tremor on Swallowing Function in a Clinical Cohort of People with Parkinson’s Disease
    Matthew Dumican, Kaitlynn Harper, Julia Stankiewicz · 2024 · Dysphagia
90. Home Monitoring of Sleep Disturbances in Parkinson’s Disease: A Wearable Solution
    Irene Rechichi, Luca Di Gangi, Maurizio Zibetti, Gabriella Olmo · 2024 · IEEE International Conference on Pervasive Computing and Communications Workshops (PerCom Workshops)
91. Tiny Carriers, Tremendous Hope: Nanomedicine in the Fight against Parkinson’s
    Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare · 2024 · Journal of dementia and Alzheimer's disease
92. Proteome and ubiquitinome analyses of the brain cortex in K18-hACE2 mice infected with SARS-CoV-2
    Qiaochu Wang, Wanjun Peng, Yehong Yang, Yue Wu, Rong Han, Tao Ding, Xutong Zhang, Jiangning Liu, Juntao Yang, Jiangfeng Liu · 2024 · iScience
93. A Knowledge-Driven Framework Discovers Brain ACtivation-Transition-Spectrum (ACTS) Features for Parkinson’s Disease
    Jiewei Lu, Jin Wang, Yuanyuan Cheng et al. · 2024 · IEEE Transactions on Neural Systems and Rehabilitation Engineering
94. The Neuroprotective and Anxiolytic Effects of Magnesium Sulfate on Retinal Dopaminergic Neurons in 6-OHDA-Induced Parkinsonian Rats: A Pilot Study
    Leyi Huang, Renxi Lin, Chunying Zhang, Shaoqing Zheng, Yiyang Wang, Zeyu Wu, Sihao Chen, Yihan Shen, Guoheng Zhang, Yuanlin Qi et al. · 2024 · Brain Sciences
95. Decrease of KATP channel expression through D3 receptor-mediated GSK3β signaling alleviates levodopa-induced dyskinesia (LID) in Parkinson's disease mouse model
    Yi‐Ying Kuo, Sih-Yu Pen, Chia-Hui Cheng, Wan-Chen Ho, Ching-Yi Chen, Wen‐Chung Wu, Ho-Hsuan Chou, Jung-Yao Chen, Ching‐Han Lin, Jen-Feng Lin et al. · 2024 · Life Sciences
96. Effectiveness of non-invasive vagal nerve stimulation in Parkinson’s disease: A comprehensive systematic review and meta-analysis
    Moaz Elsayed Abouelmagd, Obai Yousef, Ismail Ibrahim, Ahmed Elshahat · 2024 · Journal of Clinical Neuroscience
97. RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stress
    Janna E. Jernigan, Hannah A. Staley, Zachary Baty, MacKenzie L. Bolen, Beatriz Nuñes Gomes, Jenny Holt, Cassandra L. Cole, Noelle K. Neighbarger, Kruthika Dheeravath, Andrea R. Merchak et al. · 2025 · Journal of Neuroinflammation
98. Identification of Key Active Constituents in Eucommia ulmoides Oliv. Leaves Against Parkinson’s Disease and the Alleviative Effects via 4E-BP1 Up-Regulation
    Yuqing Li, Ruidie Shi, Lijie Xia, Xuanming Zhang, Pengyu Zhang, Siyuan Liu, Kechun Liu, Attila Gabor SIK, Rostyslav S. Stoika, Meng Jin · 2025 · International Journal of Molecular Sciences
99. NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease
    Bita Firouzan, Rasoul Ghasemi, Michael T. Tetteh, John B. Matson, Khosrow Kashfi · 2025 · European Journal of Pharmacology
100. Insights into gait performance in Parkinson's disease via latent features of deep graph neural networks
     Jiecheng Wu, Ning Su, Xinjin Li · 2025 · Frontiers in Neurology